COPD Set to Reach About 600 Million Cases Worldwide by 2050

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Dec. 11, 2023 -- The prevalence of chronic obstructive pulmonary disease (COPD) is projected to continue increasing through 2050, approaching 600 million patients with COPD globally by 2050, according to a study published online Dec. 7 in JAMA Network Open.

Elroy Boers, Ph.D., from ResMed Science Center in Halifax, Nova Scotia, Canada, and colleagues conducted a modeling study to examine the global burden of COPD through 2050 considering COPD risk factors. Generalized additive models were developed, which included smoking prevalence, indoor and outdoor air pollution, and development indices as predictors to project global COPD prevalence.

The researchers estimate that from 2020 to 2050, the number of COPD cases will increase by 23 percent globally among those aged 25 years and older, approaching 600 million patients with COPD globally by 2050. The growth in COPD burden was projected to be largest among women and in low- and middle-income regions. By 2050, the number of cases in women was projected to increase by 47.1 percent compared with a 9.4 percent increase in men, and the number of cases in low- and middle-income regions was projected to be more than double that of high-income regions.

"Further research, prevention, and advocacy is needed to address these issues so that adequate preparation and resource allocation can take place," the authors write.

Several authors disclosed ties to ResMed, which funded the study.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-12 22:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords